Literature DB >> 20398009

The role of proinflammatory cytokines in the generation and maintenance of joint pain.

H-G Schaible1, G Segond von Banchet, M K Boettger, R Bräuer, M Gajda, F Richter, S Hensellek, D Brenn, G Natura.   

Abstract

The proinflammatory cytokines tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) not only promote and maintain inflammation, they also contribute to the generation and maintenance of inflammatory pain by acting at nociceptive nerve cells. A large proportion of dorsal root ganglion (DRG) neurons express TNF receptors and receptor units for stimulation with IL-6. In the rat model of antigen-induced arthritis (AIA), neutralization of TNF-alpha by etanercept and infliximab reduced inflammation-evoked mechanical hyperalgesia at the inflamed knee joint. This treatment also attenuated the infiltration of macrophages into the DRGs usually observed during the acute phase of AIA. Intra-articular application of etanercept reduced the responses of C-fibers to mechanical stimulation of the inflamed joint but did not influence responses to stimulation of the normal joint. Finally, in cultured DRG neurons TNF-alpha increased the proportion of neurons that express the TRPV1 receptor and may thus contribute to the generation of inflammation-evoked thermal hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398009     DOI: 10.1111/j.1749-6632.2009.05301.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  85 in total

1.  Future directions in painful knee osteoarthritis: harnessing complexity in a heterogeneous population.

Authors:  Andrew J Kittelson; Steven Z George; Katrina S Maluf; Jennifer E Stevens-Lapsley
Journal:  Phys Ther       Date:  2013-10-31

Review 2.  Ion channels in inflammation.

Authors:  Michael Eisenhut; Helen Wallace
Journal:  Pflugers Arch       Date:  2011-01-29       Impact factor: 3.657

3.  Chikungunya fever: focus on peripheral markers of pathogenesis.

Authors:  Pierre Roques; Gabriel Gras
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

4.  Association of Pain Centralization and Patient-Reported Pain in Active Rheumatoid Arthritis.

Authors:  Andrew C Heisler; Jing Song; Dorothy D Dunlop; Alyssa Wohlfahrt; Clifton O Bingham; Marcy B Bolster; Daniel J Clauw; Wendy Marder; Kristine Phillips; Tuhina Neogi; Yvonne C Lee
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-07-21       Impact factor: 4.794

5.  Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis.

Authors:  Da P Chen; Chun K Wong; Lai S Tam; Edmund K Li; Christopher W K Lam
Journal:  Cell Mol Immunol       Date:  2011-09-26       Impact factor: 11.530

Review 6.  [Rheumatic diseases and neuropathic pain : Diagnosis and treatment].

Authors:  J Lassen; R Baron
Journal:  Z Rheumatol       Date:  2020-12-23       Impact factor: 1.372

7.  Dexmedetomidine combined with interscalene brachial plexus block has a synergistic effect on relieving postoperative pain after arthroscopic rotator cuff repair.

Authors:  Jung-Taek Hwang; Ji Su Jang; Jae Jun Lee; Dong-Keun Song; Han Na Lee; Do-Young Kim; Sang-Soo Lee; Sung Mi Hwang; Yong-Been Kim; Sanghyeon Lee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-11-26       Impact factor: 4.342

8.  Pain Intensity and Pain Interference in Older Adults: Role of Gender, Obesity and High-Sensitivity C-Reactive Protein.

Authors:  Vahid Eslami; Mindy J Katz; Robert S White; Erin Sundermann; Julie M Jiang; Ali Ezzati; Richard B Lipton
Journal:  Gerontology       Date:  2016-08-04       Impact factor: 5.140

Review 9.  Towards a mechanism-based approach to pain management in osteoarthritis.

Authors:  Anne-Marie Malfait; Thomas J Schnitzer
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

10.  Minocycline blocks lipopolysaccharide induced hyperalgesia by suppression of microglia but not astrocytes.

Authors:  S-Y Yoon; D Patel; P M Dougherty
Journal:  Neuroscience       Date:  2012-06-26       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.